SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mallardq who wrote (244)7/3/1998 11:10:00 AM
From: lucky  Read Replies (2) of 371
 
I, too, am a little tired of waiting. Have a friend who interviewed for their head of clinical research position. Company is still telling a pretty good story to potential employees. Friend opted to stay with big pharma. Apparently a pretty concerted effort underway however to develop big pharma management for Immu. I think that bodes well.

Nevertheless, this stock should be bought at $4 and sold at $5.5 to 6. You'd probably make a million dollars before those, like me, who wait for the big break out make any money.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News